(Subjects cannot enter the study if they meet any of the following conditions): 1. Patients with a history of allergy to chloroquine phosphate, lopinavir, and ritonavir, 2. Patients with hematological diseases, 3. Patients with chronic liver and kidney disease and reaching the end stage, 4. Patients with arrhythmia and chronic heart disease, 5. Patients known to have retinal disease, hearing loss or hearing loss, 6. Patients with known mental illness, 7. Patients who must use digitalis because of the original underlying disease, 8. Pancreatitis, 9. Hemophilia, 10. Broad bean disease, 11. Female patients during pregnancy.

(Subjects cannot enter the study if they meet any of the following conditions): 1. Patients with a history of allergy to chloroquine phosphate, lopinavir, and ritonavir, 2. Patients with hematological diseases, 3. Patients with chronic liver and kidney disease and reaching the end stage, 4. Patients with arrhythmia and chronic heart disease, 5. Patients known to have retinal disease, hearing loss or hearing loss, 6. Patients with known mental illness, 7. Patients who must use digitalis because of the original underlying disease, 8. Pancreatitis, 9. Hemophilia, 10. Broad bean disease, 11. Female patients during pregnancy.